{"Title": "Biotin in progressive multiple sclerosis: A new lead?", "Year": 2016, "Source": "Mult. Scler.", "Volume": "22", "Issue": 13, "Art.No": null, "PageStart": 1640, "PageEnd": 1641, "CitedBy": 5, "DOI": "10.1177/1352458516676387", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84994565827&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Biotin", "Humans", "Multiple Sclerosis", "Multiple Sclerosis, Chronic Progressive"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84994565827", "SubjectAreas": [["Neurology", "NEUR", "2808"], ["Neurology (clinical)", "MEDI", "2728"]], "AuthorData": {"57212501583": {"Name": "Chataway J.", "AuthorID": "57212501583", "AffiliationID": "60019953, 60022148, 60176027", "AffiliationName": "Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London"}}}